Meeting
2018 Genitourinary Cancers Symposium
Prognostic impact of DNA repair germline variants in hormone sensitive prostate cancer stage.
Authors
Manish Kohli
Mayo Clinic, Rochester, MN
Manish Kohli , Steven Hart , Jenna Lilyquist , Chunling Hu , David W. Hillman , Kun Lee , Rohan David Gnanaolivu , Eric Polley , Fergus Couch
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 262)
DOI
10.1200/JCO.2018.36.6_suppl.262
Abstract #
262
Poster Bd #
M16
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2023 ASCO Annual Meeting
HRD signature and HRD genomic landscape of tumors from 896 patients with early-stage breast cancer (BC).
First Author: June Evelyn Jeon
Poster
2023 ASCO Annual Meeting
A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.
First Author: Elias Chandran
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan